We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+4.78%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$477M
AUM Growth
+$6.42M
(+1.4%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
75.49%
Holding
73
New
5
Increased
26
Reduced
20
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$1.39M |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$1.35M |
| 3 |
State Street SPDR S&P Dividend ETF
SDY
|
+$1.21M |
| 4 |
First Trust Global Tactical Commodity Strategy Fund
FTGC
|
+$968K |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$815K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Europe ETF
VGK
|
+$5.04M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$1.71M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.58M |
| 4 |
iShares MSCI Pacific ex Japan ETF
EPP
|
+$1.36M |
| 5 |
Halozyme
HALO
|
+$920K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.04% |
| 2 | Healthcare | 2.02% |
| 3 | Real Estate | 0.38% |
| 4 | Consumer Staples | 0.23% |
| 5 | Materials | 0.14% |
Similar funds
MBA
SIA
AP
MW
SBIA
LC
TW
PAME
Callan Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Callan Capital held 73 positions worth $477M, up 1.4% from $470M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Callan Capital withdrew a net $17.8M in Q2 2015, closing 3 positions and reducing 20 holdings. Its most notable exit was Halozyme, an estimated $920K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, down from 97% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Callan Capital opened a new position in PIMCO Enhanced Short Maturity Active Exchange-Traded Fund worth $815K.
- Callan Capital's largest Q2 2015 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 8,054 shares worth $815K.
- Callan Capital added most to Becton Dickinson in Q2 2015, an estimated $1.39M increase.
- Callan Capital's biggest Q2 2015 reduction was Vanguard FTSE Europe ETF, cutting an estimated $5.04M.
- Callan Capital fully exited Halozyme in Q2 2015, selling an estimated $920K.
- Callan Capital's ten largest holdings make up 75% of its $477M portfolio in Q2 2015.
- Callan Capital opened 5 new positions and closed 3 in Q2 2015.
- Callan Capital's portfolio value rose 1.4% quarter-over-quarter to $477M.
Based on Callan Capital's 13F filing for Q2 2015, filed 13 Aug 2015.